查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1553553

覆膜支架市場規模、佔有率、趨勢分析報告：按產品、最終用途、地區、細分市場預測，2024-2030 年

Covered Stent Market Size, Share & Trends Analysis Report By Product (Vascular Stent, Non-vascular Stent), By End Use (Hospitals, Ambulatory Care Centers (ACS), Specialty Clinics), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

覆膜支架市場規模及趨勢：

2023年全球覆膜支架市場規模預估為11.3億美元，預估2024年至2030年複合年成長率為4.1%。

該市場的成長是由血管疾病盛行率的增加、覆膜支架技術的進步、認知和診斷的提高以及應用和適應症範圍的擴大所推動的。 2024年4月，美國心臟協會宣布，全球下肢周邊動脈疾病（PAD）盛行率高達116至2.3億人，報告指出這是推動支架需求增加的主要因素。這種高盛行率凸顯了對有效血管介入的迫切需求，並將覆膜支架作為管理 PAD 和改善全球患者照護的重要解決方案。

覆膜支架的技術進步正在推動市場成長。 MDPI 2023 年 2 月的一篇報導強調，覆膜支架現在採用聚四氟乙烯 (PTFE) 等先進的生物相容性聚合物設計。這些材料可作為組織浸潤的屏障，大大降低了血管再阻塞的風險。此外，它在隔離暴露的發炎表面方面可能特別有效，並可能有助於抑制新內膜增生的發展。

此外，到 2023 年 11 月，3D 列印技術將徹底改變根據每位患者獨特的解剖結構量身定做的個人化覆膜支架的製作方法。這種方法可以製造具有客製化尺寸和機械性能的支架，從而提高其性能和在脈管系統中的整合。此外，最新一代的覆膜支架還具有藥物釋放型功能，可局部輸送抗增生藥物，進一步降低再血管再阻塞的風險。正在進行的研究正在調查多種藥物的順序釋放，以最佳化癒合過程並最大限度地減少併發症。

覆膜支架的卓越功效是市場成長的主要動力。 Elsevier Ltd. 於 2024 年 4 月發表的一篇論文強調了覆膜支架在治療慢性腸系膜缺血方面相對於裸金屬支架的優越性。在荷蘭六個中心進行的一項研究發現，覆膜支架的長期通暢率明顯更高，81% 的覆膜支架在 24 個月內實現了初步通暢，而裸金屬支架只有 49% 保持其存在。這些性能改進支持了人們對覆膜支架日益成長的偏好，並推動了它們在血管內手術中的採用。

提高意識和診斷是推動市場成長的關鍵因素。根據耶魯大學醫學院 2023 年 9 月發表的一篇論文，9 月被指定為全國周邊動脈疾病(PAD) 宣傳月。該舉措旨在透過教育人們了解周邊動脈疾病的危險因子、症狀和早期診斷的重要性，提高大眾對周邊動脈疾病的認知。在整個月中，各種組織將提供支持，提供教育材料，並鼓勵高風險族群接受血管篩檢。主要目的是強調早期發現和治療的重要性，以預防與 PAD 相關的嚴重併發症。

此外，2021 年 3 月進行的一項國際調查評估了各國對 PAD 的認知水平，結果顯示 57% 的參與者不了解 PAD，凸顯了知識差距。這項調查也證實，不同國家和年齡層的認知有差異，凸顯了進行有針對性的認知活動的必要性。這些發現旨在幫助醫療保健提供者和政策制定者進行更有效的教育宣傳活動，以解決當前 PAD 意識方面的缺陷。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章全球覆膜支架市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場推動要素分析
    • 市場限制因素分析
  • 覆膜支架市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章 覆膜支架市場：依產品估算與趨勢分析

  • 覆膜支架市場：依產品分類的儀表板
  • 覆膜支架市場：產品變化分析
  • 2018-2030 年覆膜支架市場規模、預測與趨勢分析（按產品）
  • 血管支架
  • 非血管支架

第5章 覆膜支架市場：依最終用途分類的估算與趨勢分析

  • 覆膜支架市場：依最終用途分類的儀表板
  • 覆膜支架市場：最終用途變化分析
  • 2018-2030 年覆膜支架市場規模、預測與趨勢分析（依最終用途）
  • 醫院
  • 門診護理中心 (ACS)
  • 專科診所

第6章 覆膜支架市場：依國家、產品和最終用途進行的區域估計和趨勢分析

  • 全球覆膜支架市場：區域儀表板
  • 2018-2030年市場規模及預測趨勢分析
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第7章 競爭格局

  • 主要製造商的最新趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商情況
    • 主要經銷商及通路夥伴名單
    • 主要客戶
    • 2023年主要企業市場佔有率分析
    • Boston Scientific Corporation
    • Medtronic
    • Biotronik SE &Co. KG
    • WL Gore &Associates, Inc.
    • Cook
    • Terumo Corporation
    • B. Braun Interventional Systems, Inc.
    • BD
    • Getinge
Product Code: GVR-4-68040-421-3

Covered Stent Market Size & Trends:

The global covered stent market size was estimated at USD 1.13 billion in 2023 and is projected to grow at a CAGR of 4.1% from 2024 to 2030. The market's growth is driven by the increasing prevalence of vascular diseases, advancements in covered stent technology, greater awareness and diagnosis, and the expanding range of applications and indications. In April 2024, the American Heart Association, Inc. reported that the global prevalence of lower extremity peripheral artery disease (PAD), affecting between 116 and 230 million people, is a major factor driving the increased demand for covered stents. This high prevalence underscores the urgent need for effective vascular interventions, positioning covered stents as a critical solution for managing PAD and enhancing patient care worldwide.

Technological advancements in covered stents are propelling the market growth. A February 2023 article by MDPI highlights that covered stents are now being designed with advanced biocompatible polymers, such as polytetrafluoroethylene (PTFE). These materials serve as barriers to prevent tissue ingrowth, significantly reducing the risk of restenosis. Additionally, they are particularly effective in sealing off exposed inflammatory surfaces, which may help inhibit the development of neointimal hyperplasia.

Moreover, in November 2023, 3D printing technology is revolutionizing the creation of personalized covered stents tailored to match the unique anatomical structures of individual patients. This approach allows the production of stents with customized dimensions and mechanical properties, improving their performance and integration within the vascular system. Furthermore, the latest generations of covered stents incorporate drug-eluting capabilities, enabling localized delivery of anti-proliferative drugs to mitigate the risk of restenosis further. Ongoing research is exploring the sequential release of multiple drugs to optimize healing processes and minimize complications.

The superior efficacy of covered stents is a key driver of market growth. An article published by Elsevier Ltd. in April 2024 highlights the advantages of covered stents over bare-metal stents in treating chronic mesenteric ischemia. A study conducted across six centers in the Netherlands found that covered stents had significantly better long-term patency, with 81% maintaining primary patency at 24 months, compared to just 49% for bare-metal stents. This enhanced performance underscores the increasing preference for covered stents, fueling their adoption in vascular procedures.

Increased awareness and diagnosis are key factors driving market growth. According to a Yale School of Medicine article published in September 2023, September has been designated as National Peripheral Artery Disease (PAD) Awareness Month. This initiative aims to raise public awareness about PAD by educating people on its risk factors, symptoms, and the importance of early diagnosis. Throughout the month, various organizations conduct outreach efforts, provide educational materials, and encourage at-risk individuals to undergo vascular screenings. The primary goal is to emphasize the importance of early detection and treatment to prevent serious complications associated with PAD.

Additionally, international surveys conducted in March 2021 assessed public awareness of PAD in various countries, revealing that 57% of participants were unfamiliar with the condition, highlighting a significant knowledge gap. The surveys also identified variations in awareness between countries and across age groups, underscoring the need for targeted awareness initiatives. These findings aim to assist healthcare providers and policymakers in developing more effective educational campaigns to address the current shortcomings in PAD awareness.

Global Covered Stent Market Report Segmentation

This report forecasts revenue growth at global, regional & country levels and provides an analysis of the industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global covered stent market report based on product, end use, and region:

  • Product Outlook (Revenue, USD Million, 2018 - 2030)
  • Vascular Stent
  • Non-vascular Stent
  • End Use Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospitals
  • Ambulatory Care Centers (ACS)
  • Specialty Clinics
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. End Use
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecast timeline.
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity price analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product Segment
    • 2.2.2. End Use Segment
    • 2.2.3. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. Global Covered Stent Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising prevalence of vascular diseases
      • 3.2.1.2. Technological advancements in covered stent
      • 3.2.1.3. Increased awareness and diagnosis
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of covered stents
      • 3.2.2.2. Regulatory compliance
  • 3.3. Covered Stent Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Covered Stent Market: Product Estimates & Trend Analysis

  • 4.1. Covered Stent Market: Product Dashboard
  • 4.2. Covered Stent Market: Product Movement Analysis
  • 4.3. Covered Stent Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Vascular Stent
    • 4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5. Non-vascular Stent
    • 4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Covered Stent Market: End Use Estimates & Trend Analysis

  • 5.1. Covered Stent Market: End Use Dashboard
  • 5.2. Covered Stent Market: End Use Movement Analysis
  • 5.3. Covered Stent Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 5.4. Hospitals
    • 5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5. Ambulatory Care Centers (ACS)
    • 5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.6. Specialty Clinics
    • 5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Covered Stent Market: Regional Estimates & Trend Analysis by Country, Product, & End Use

  • 6.1. Global Covered Stent Market: Regional Dashboard
  • 6.2. Market Size & Forecasts Trend Analysis, 2018 to 2030
  • 6.3. North America
    • 6.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Key country dynamics
      • 6.3.2.2. Regulatory framework/ reimbursement structure
      • 6.3.2.3. Competitive scenario
      • 6.3.2.4. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Key country dynamics
      • 6.3.3.2. Regulatory framework/ reimbursement structure
      • 6.3.3.3. Competitive scenario
      • 6.3.3.4. Canada market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.3.4. Mexico
      • 6.3.4.1. Key country dynamics
      • 6.3.4.2. Regulatory framework/ reimbursement structure
      • 6.3.4.3. Competitive scenario
      • 6.3.4.4. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.4. Europe
    • 6.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.4.2. UK
      • 6.4.2.1. Key country dynamics
      • 6.4.2.2. Regulatory framework/ reimbursement structure
      • 6.4.2.3. Competitive scenario
      • 6.4.2.4. UK market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.3. Germany
      • 6.4.3.1. Key country dynamics
      • 6.4.3.2. Regulatory framework/ reimbursement structure
      • 6.4.3.3. Competitive scenario
      • 6.4.3.4. Germany market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.4. France
      • 6.4.4.1. Key country dynamics
      • 6.4.4.2. Regulatory framework/ reimbursement structure
      • 6.4.4.3. Competitive scenario
      • 6.4.4.4. France market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.5. Italy
      • 6.4.5.1. Key country dynamics
      • 6.4.5.2. Regulatory framework/ reimbursement structure
      • 6.4.5.3. Competitive scenario
      • 6.4.5.4. Italy market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.6. Spain
      • 6.4.6.1. Key country dynamics
      • 6.4.6.2. Regulatory framework/ reimbursement structure
      • 6.4.6.3. Competitive scenario
      • 6.4.6.4. Spain market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.7. Sweden
      • 6.4.7.1. Key country dynamics
      • 6.4.7.2. Regulatory framework/ reimbursement structure
      • 6.4.7.3. Competitive scenario
      • 6.4.7.4. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.8. Norway
      • 6.4.8.1. Key country dynamics
      • 6.4.8.2. Regulatory framework/ reimbursement structure
      • 6.4.8.3. Competitive scenario
      • 6.4.8.4. Norway market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.9. Denmark
      • 6.4.9.1. Key country dynamics
      • 6.4.9.2. Regulatory framework/ reimbursement structure
      • 6.4.9.3. Competitive scenario
      • 6.4.9.4. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.2. China
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. China market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.3. Japan
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework/ reimbursement structure
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. Japan market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.4. India
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Regulatory framework/ reimbursement structure
      • 6.5.4.3. Competitive scenario
      • 6.5.4.4. India market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.5. Australia
      • 6.5.5.1. Key country dynamics
      • 6.5.5.2. Regulatory framework/ reimbursement structure
      • 6.5.5.3. Competitive scenario
      • 6.5.5.4. Australia market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.6. Thailand
      • 6.5.6.1. Key country dynamics
      • 6.5.6.2. Regulatory framework/ reimbursement structure
      • 6.5.6.3. Competitive scenario
      • 6.5.6.4. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.7. South Korea
      • 6.5.7.1. Key country dynamics
      • 6.5.7.2. Regulatory framework/ reimbursement structure
      • 6.5.7.3. Competitive scenario
      • 6.5.7.4. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.6. Latin America
    • 6.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.6.2. Brazil
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework/ reimbursement structure
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.7. MEA
    • 6.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.7.2. Saudi Arabia
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.7.3. South Africa
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework/ reimbursement structure
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.7.4. UAE
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework/ reimbursement structure
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. UAE market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.7.5. Kuwait
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Regulatory framework/ reimbursement structure
      • 6.7.5.3. Competitive scenario
      • 6.7.5.4. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Manufacturers
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Key company market share analysis, 2023
    • 7.3.4. Boston Scientific Corporation
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Product benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. Medtronic
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Product benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. Biotronik SE & Co. KG
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Product benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. W. L. Gore & Associates, Inc.
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Product benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. Cook
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Product benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. Terumo Corporation
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Product benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. B. Braun Interventional Systems, Inc.
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Product benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. BD
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Product benchmarking
      • 7.3.11.4. Strategic initiatives
    • 7.3.12. Getinge
      • 7.3.12.1. Company overview
      • 7.3.12.2. Financial performance
      • 7.3.12.3. Product benchmarking
      • 7.3.12.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global covered stent market, by product, 2018 - 2030 (USD Million)
  • Table 4 Global covered stent market by end use, 2018 - 2030
  • Table 5 Global Covered Stent market, by region, 2018 - 2030 (USD Million)
  • Table 6 North America covered stent market by country, 2018 - 2030 (USD Million)
  • Table 7 North America covered stent market by product, 2018 - 2030 (USD Million)
  • Table 8 North America covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 9 U.S covered stent market, by product, 2018 - 2030 (USD Million)
  • Table 10 U.S covered stent market, by end use, 2018 - 2030 (USD Million)
  • Table 11 Canada covered stent market by product, 2018 - 2030 (USD Million)
  • Table 12 Canada covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 13 Mexico covered stent market by product, 2018 - 2030 (USD Million)
  • Table 14 Mexico covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 15 Europe covered stent market by country, 2018 - 2030 (USD Million)
  • Table 16 Europe covered stent market by product, 2018 - 2030 (USD Million)
  • Table 17 Europe covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 18 UK covered stent market by product, 2018 - 2030 (USD Million)
  • Table 19 UK covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 20 Germany covered stent market by product, 2018 - 2030 (USD Million)
  • Table 21 Germany covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 22 France covered stent market by product, 2018 - 2030 (USD Million)
  • Table 23 France covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 24 Italy covered stent market by product, 2018 - 2030 (USD Million)
  • Table 25 Italy covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 26 Spain covered stent market by product, 2018 - 2030 (USD Million)
  • Table 27 Spain covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 28 Denmark covered stent market by product, 2018 - 2030 (USD Million)
  • Table 29 Denmark covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 30 Sweden covered stent market by product, 2018 - 2030 (USD Million)
  • Table 31 Sweden covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 32 Norway covered stent market by product, 2018 - 2030 (USD Million)
  • Table 33 Norway covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific covered stent market by country, 2018 - 2030 (USD Million)
  • Table 35 Asia Pacific covered stent market by product, 2018 - 2030 (USD Million)
  • Table 36 Asia Pacific covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 37 Japan covered stent market by product, 2018 - 2030 (USD Million)
  • Table 38 Japan covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 39 China covered stent market by product, 2018 - 2030 (USD Million)
  • Table 40 China covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 41 India covered stent market by product, 2018 - 2030 (USD Million)
  • Table 42 India covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 43 Australia covered stent market by country, 2018 - 2030 (USD Million)
  • Table 44 Australia covered stent market by product, 2018 - 2030 (USD Million)
  • Table 45 Australia covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 46 Thailand covered stent market by product, 2018 - 2030 (USD Million)
  • Table 47 Thailand covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 48 South Korea covered stent market by product, 2018 - 2030 (USD Million)
  • Table 49 South Korea covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 50 Latin America covered stent market by country, 2018 - 2030 (USD Million)
  • Table 51 Latin America covered stent market by product, 2018 - 2030 (USD Million)
  • Table 52 Latin America covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 53 Brazil covered stent market by product, 2018 - 2030 (USD Million)
  • Table 54 Brazil covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 55 Argentina covered stent market by product, 2018 - 2030 (USD Million)
  • Table 56 Argentina covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 57 MEA covered stent market, by country, 2018 - 2030 (USD Million)
  • Table 58 MEA covered stent market by product, 2018 - 2030 (USD Million)
  • Table 59 MEA covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 60 South Africa covered stent market by product, 2018 - 2030 (USD Million)
  • Table 61 South Africa covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 62 Saudi Arabia covered stent market by product, 2018 - 2030 (USD Million)
  • Table 63 Saudi Arabia covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 64 UAE covered stent market by product, 2018 - 2030 (USD Million)
  • Table 65 UAE covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 66 Kuwait covered stent market by product, 2018 - 2030 (USD Million)
  • Table 67 Kuwait covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 68 Participant's overview
  • Table 69 Financial performance
  • Table 70 Key companies undergoing expansions
  • Table 71 Key companies undergoing acquisitions
  • Table 72 Key companies undergoing collaborations
  • Table 73 Key companies launching new products
  • Table 74 Key companies undergoing partnerships
  • Table 75 Key companies undertaking other strategies

List of Figures

  • Fig. 1 Covered stent market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain-based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Covered stent market revenues, 2023 (USD Millions)
  • Fig. 9 Market driver relevance analysis (Current & future impact)
  • Fig. 10 Market restraint relevance analysis (Current & future impact)
  • Fig. 11 Porter's Five Forces analysis
  • Fig. 12 PESTLE analysis
  • Fig. 13 Covered stent market Product outlook:
  • Fig. 14 Covered stent market: Product movement analysis
  • Fig. 15 Segment dashboard
  • Fig. 16 Global vascular stent market, 2018 - 2030 (USD Million)
  • Fig. 17 Global non-vascular stent market, 2018 - 2030 (USD Million)
  • Fig. 18 Covered stent market end use outlook:
  • Fig. 19 Covered stent market: end use movement analysis
  • Fig. 20 Global hospitals market, 2018 - 2030 (USD Million)
  • Fig. 21 Global ambulatory care centers market, 2018 - 2030 (USD Million)
  • Fig. 22 Global specialty clinics market, 2018 - 2030 (USD Million)
  • Fig. 23 Regional market place: Key takeaways
  • Fig. 24 North America covered stent market, 2018 - 2030 (USD Million)
  • Fig. 25 U.S covered stent market, 2018 - 2030 (USD Million)
  • Fig. 26 Canada covered stent market, 2018 - 2030 (USD Million)
  • Fig. 27 Mexico covered stent market, 2018 - 2030 (USD Million)
  • Fig. 28 Europe covered stent market, 2018 - 2030 (USD Million)
  • Fig. 29 Germany covered stent market, 2018 - 2030 (USD Million)
  • Fig. 30 UK covered stent market, 2018 - 2030 (USD Million)
  • Fig. 31 France covered stent market, 2018 - 2030 (USD Million)
  • Fig. 32 Italy covered stent market, 2018 - 2030 (USD Million)
  • Fig. 33 Spain covered stent market, 2018 - 2030 (USD Million)
  • Fig. 34 Asia Pacific covered stent market, 2018 - 2030 (USD Million)
  • Fig. 35 Japan covered stent market, 2018 - 2030 (USD Million)
  • Fig. 36 China covered stent market, 2018 - 2030 (USD Million)
  • Fig. 37 India covered stent market, 2018 - 2030 (USD Million)
  • Fig. 38 Australia covered stent market, 2018 - 2030 (USD Million)
  • Fig. 39 Latin America covered stent market, 2018 - 2030 (USD Million)
  • Fig. 40 Brazil covered stent market, 2018 - 2030 (USD Million)
  • Fig. 41 MEA covered stent market, 2018 - 2030 (USD Million)
  • Fig. 42 South Africa covered stent market, 2018 - 2030 (USD Million)
  • Fig. 43 Saudi Arabia covered stent market, 2018 - 2030 (USD Million)
  • Fig. 44 Market Participant Categorization
  • Fig. 45 Strategy mapping